Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study
暂无分享,去创建一个
D. Galloway | M. Wener | P. Nghiem | C. Morishima | S. Bhatia | M. Kawasumi | M. Redman | A. Lisberg | J. Carter | K. Paulson | J. Iyer | W. Simonson | A. Blom | K. Hutchinson | E. Tarabadkar | C. Lewis | Ata S. Moshiri | D. Ritter | Lola Mudgistratova | Joseph J. Carter
[1] P. Nghiem,et al. Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma , 2016, Cancer medicine.
[2] Drew M. Pardoll,et al. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. , 2016, The New England journal of medicine.
[3] P. Coursaget,et al. Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma , 2016, The British journal of dermatology.
[4] A. Birnbaum,et al. Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas , 2015, Cureus.
[5] P. Nghiem,et al. How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model , 2015, The Journal of investigative dermatology.
[6] A. Giobbie-Hurder,et al. Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome , 2014, Journal of Immunotherapy for Cancer.
[7] F. Zhu,et al. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma. , 2014, Journal of the American Academy of Dermatology.
[8] T. Olencki,et al. Merkel cell carcinoma, version 1.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] P. Coursaget,et al. Molecular Epidemiology of Merkel Cell Polyomavirus: Evidence for Geographically Related Variant Genotypes , 2014, Journal of Clinical Microbiology.
[10] G. Blair,et al. Merkel Cell Polyomavirus Small T Antigen Targets the NEMO Adaptor Protein To Disrupt Inflammatory Signaling , 2013, Journal of Virology.
[11] I. Cornet,et al. The T Antigen Locus of Merkel Cell Polyomavirus Downregulates Human Toll-Like Receptor 9 Expression , 2013, Journal of Virology.
[12] P. Coursaget,et al. Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[13] C. Camacho,et al. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7. , 2013, Cell host & microbe.
[14] E. M. Warton,et al. Systemic immune suppression as a stage-independent predictor of diminished Merkel cell carcinoma-specific survival , 2012, The Journal of investigative dermatology.
[15] J. Cerhan,et al. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] D. Kraus,et al. Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution , 2011, Annals of surgery.
[17] P. Coursaget,et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] O. Ruuskanen,et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] D. Galloway,et al. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. , 2010, Cancer research.
[20] Yuan Chang,et al. Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens , 2010, Journal of Virology.
[21] P. Coursaget,et al. Generation of Merkel Cell Polyomavirus (MCV)-Like Particles and Their Application to Detection of MCV Antibodies , 2010, Journal of Clinical Microbiology.
[22] D. Henson,et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study , 2010, Journal of cutaneous pathology.
[23] J. Goedert,et al. Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome , 2009, International journal of cancer.
[24] D. Galloway,et al. Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma , 2009, Journal of the National Cancer Institute.
[25] S. Swerdlow,et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors , 2009, International journal of cancer.
[26] J. Becker,et al. Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus , 2009, PLoS pathogens.
[27] H. Joensuu,et al. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. , 2009, Journal of the National Cancer Institute.
[28] Yuan Chang,et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus , 2008, Proceedings of the National Academy of Sciences.
[29] Arash Mostaghimi,et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. , 2008, Journal of the American Academy of Dermatology.
[30] P. Moore,et al. Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.